|
C4ORF46 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05869999999608E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23379999994455E-06 |
| Normal-vs-Stage2 |
3.533900E-02 |
| Normal-vs-Stage3 |
4.052300E-02 |
| Normal-vs-Stage4 |
7.259400E-03 |
| Stage1-vs-Stage2 |
6.906000E-01 |
| Stage1-vs-Stage3 |
2.179500E-02 |
| Stage1-vs-Stage4 |
4.102600E-01 |
| Stage2-vs-Stage3 |
3.965800E-01 |
| Stage2-vs-Stage4 |
8.924600E-01 |
| Stage3-vs-Stage4 |
3.312000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.61269999999969E-05 |
| Normal-vs-AfricanAmerican |
1.563590E-02 |
| Normal-vs-Asian |
8.426400E-02 |
| Caucasian-vs-AfricanAmerican |
8.581000E-01 |
| Caucasian-vs-Asian |
1.353240E-01 |
| AfricanAmerican-vs-Asian |
1.410830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75624999999568E-05 |
| Normal-vs-Female |
1.419220E-03 |
| Male-vs-Female |
2.973600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.743600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.72700999999664E-05 |
| Normal-vs-Age(61-80Yrs) |
1.263230E-03 |
| Normal-vs-Age(81-100Yrs) |
6.378200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.901600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.857540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.696400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.516100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.018000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.898230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.218500E-03 |
| Normal-vs-Grade 2 |
2.09770000036968E-07 |
| Normal-vs-Grade 3 |
1.240310E-02 |
| Normal-vs-Grade 4 |
4.570400E-02 |
| Grade 1-vs-Grade 2 |
8.426200E-01 |
| Grade 1-vs-Grade 3 |
1.163370E-01 |
| Grade 1-vs-Grade 4 |
3.962400E-01 |
| Grade 2-vs-Grade 3 |
2.563500E-04 |
| Grade 2-vs-Grade 4 |
6.079600E-02 |
| Grade 3-vs-Grade 4 |
6.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.35719999999162E-05 |
| Normal-vs-ccB subtype |
1.603140E-04 |
| ccA subtype-vs-ccB subtype |
9.990600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.76380000000265E-05 |
| Normal-vs-N1 |
2.256100E-02 |
| N0-vs-N1 |
4.631200E-01 |
|
|
